Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 7/20 | 0.49 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
| ▸ | RORC | P51449 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | BMP1 | P13497 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6802936 | 0.83 | CNR2 (0.53) | CNR2BACE1RORCTP53BMP1 | |
| SCHEMBL6803763 | 0.81 | CNR2 (0.48) | CNR2BACE1RORCTP53BMP1 | |
| SCHEMBL28211577 | 0.69 | TAS2R14 (0.65) | CNR2RORCALDH1A1TAS2R14 | |
| SCHEMBL17050185 | 0.68 | RORC (0.50) | CNR2RORCKMT2ACA12CA2 | |
| SCHEMBL24356470 | 0.67 | GRIN2D (0.40) | TP53ALDH1A1KMT2A | |
| SCHEMBL7092691 | 0.66 | CNR2 (0.57) | CNR2ALDH1A1CA12CA2CA9 | |
| SCHEMBL22469193 | 0.66 | CNR2 (0.72) | CNR2BACE1TP53MEN1ALDH1A1 | |
| SCHEMBL6803887 | 0.66 | CNR2 (0.56) | CNR2TP53BMP1MEN1ALDH1A1 | |
| SCHEMBL218536 | 0.66 | SMN1; SMN2 (0.68) | CNR2ALDH1A1CA12CA2CA9 | |
| SCHEMBL6954421 | 0.66 | TAS2R14 (0.53) | CNR2RORCMEN1KMT2ACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | THE PROCTER & GAMBLE COMPANY | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | PTPRM, PTPRS, PTPRE | CNR2 4684/4885BACE1 4410/4885RORC 2471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.